Valacyclovir Dosage for Cold Sores
For cold sores (herpes labialis) in adults and adolescents ≥12 years, the recommended dose is valacyclovir 2 grams twice daily for 1 day, with doses taken 12 hours apart, initiated at the earliest symptom (tingling, itching, or burning). 1
Dosing Regimen
The FDA-approved regimen is straightforward:
- 2 grams in the morning
- 2 grams 12 hours later (evening)
- Total treatment duration: 1 day only
This high-dose, short-duration approach is supported by both the FDA label 1 and clinical trial evidence 2.
Timing is Critical
Initiate treatment at the prodromal stage (tingling, itching, burning) before visible lesions develop. The medication is most effective when started early:
- Treatment initiated after visible lesions (papule, vesicle, ulcer) has no established efficacy data 1
- Early initiation reduces episode duration by approximately 1 day compared to placebo 2
- Time to lesion healing and cessation of pain/discomfort are significantly reduced with early treatment 2
Clinical Efficacy
The 1-day valacyclovir regimen demonstrated in randomized controlled trials 2:
- Reduced median episode duration by 1.0 day (p=0.001)
- Reduced mean episode duration by 1.1 days
- Prevented or blocked lesion development in an additional 6.4% of patients
- Comparable safety profile to placebo
Guideline evidence confirms this regimen shows shorter median episode duration (4.0-5.0 days with valacyclovir vs 5.0 days with placebo, p<0.001) 3.
Renal Dosing Adjustments
For patients with impaired renal function 1:
- CrCl 30-49 mL/min: No dose reduction needed
- CrCl 10-29 mL/min: 1 gram every 24 hours (total 2 doses over 2 days)
- CrCl <10 mL/min: 500 mg every 24 hours (total 2 doses over 2 days)
- Do not exceed 1 day of treatment in patients with normal renal function
Key Clinical Pearls
- Valacyclovir is not a cure for cold sores—counsel patients on recurrence 1
- Can be taken without regard to meals 1
- Advise adequate hydration 1
- The convenient 1-day regimen offers superior compliance compared to 5-day acyclovir regimens
- For pediatric patients <12 years, this indication is not FDA-approved; alternative formulations or medications should be considered
Common Pitfall to Avoid
Do not prescribe longer courses (e.g., 5-7 days) for cold sores—the evidence specifically supports the 1-day, high-dose regimen. Longer courses are reserved for other herpes infections (genital herpes, herpes zoster) but provide no additional benefit for herpes labialis and only increase cost and potential adverse effects.